Filing Details
- Accession Number:
- 0001179110-19-009217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-06 17:54:34
- Reporting Period:
- 2019-08-02
- Accepted Time:
- 2019-08-06 17:54:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1634386 | M Stephen Rodin | C/O The Medicines Company 8 Sylvan Way Parsippany NJ 07054 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-02 | 5,000 | $8.38 | 33,139 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-02 | 5,000 | $34.82 | 28,139 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock | Disposition | 2019-08-02 | 5,000 | $0.00 | 5,000 | $8.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-08-03 | No | 4 | M | Direct |
Footnotes
- Sales were effected immediately prior to the expiration of the underlying stock option pursuant to a Rule 10b-5 program adopted by Mr. Rodin in December 2018.
- Represents the weighted average sales price of the shares sold ranging from a low of $34.60 to a high of $35.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option vested in forty-eight equal installments beginning on September 3, 2009.